Uremia: Difference between revisions
Line 17: Line 17:
**Cognitive defects, memory loss, decreased attentiveness, slurred speech
**Cognitive defects, memory loss, decreased attentiveness, slurred speech
**Asterixis, seizure, coma
**Asterixis, seizure, coma
**Improves w/ dialysis
**Improves with dialysis
*Dialysis dementia
*Dialysis dementia
**Similar to uremic encephalopathy except progressive, no improvement w/ dialysis  
**Similar to uremic encephalopathy except progressive, no improvement w/ dialysis  
Line 24: Line 24:
**Cerebrovascular disease, trauma, bleeding dyscrasias, anticoagulant, HTN
**Cerebrovascular disease, trauma, bleeding dyscrasias, anticoagulant, HTN
*[[Subdural hematoma]]
*[[Subdural hematoma]]
**10x more likely than in general population
**10 times more likely than in general population
**Headache, focal neurologic deficits, seizure, coma
**Headache, focal neurologic deficits, seizure, coma
*Peripheral neuropathy
*Peripheral neuropathy
Line 33: Line 33:
===Cardiovascular===
===Cardiovascular===
*CK-MB and troponin are specific markers of MI even in patients undergoing regular dialysis
*CK-MB and troponin are specific markers of MI even in patients undergoing regular dialysis
*Mortality from CV disease is 10-30x higher in dialysis patients than general population
*Mortality from CV disease is 10-30 times higher in dialysis patients than general population
*HTN is common
*HTN is common
*Uremic cardiomyopathy
*Uremic cardiomyopathy
Line 52: Line 52:
***Dialysis
***Dialysis
*[[Tamponade]]
*[[Tamponade]]
**Presents w/ AMS, hypotension, dyspnea
**Presents with altered mental status, hypotension, dyspnea
***Rarely present w/ classic signs of Beck's triad
***Rarely present w/ classic signs of Beck's triad
**Pericardiocentesis should only be attempted if hemodynamically unstable
**Pericardiocentesis should only be attempted if hemodynamically unstable
*[[Pulmonary Edema]]
*[[Pulmonary Edema]]
**Commonly ascribed to fluid overload; also consider MI
**Commonly ascribed to fluid overload; also consider MI
***Treat similar to non-ESRD pt
***Treat similar to non-ESRD patient
****Lasix 80mg IV may be effective even if minimal Urine output (pulmonary vasodilation)
****Lasix 80mg IV may be effective even if minimal urine output (pulmonary vasodilation)
***Preload reduction can be accomplished via:
***Preload reduction can be accomplished via:
****Induced diarrhea (sorbitol)
****Induced diarrhea (sorbitol)
Line 68: Line 68:
===Hematologic===
===Hematologic===
*[[Anemia]]
*[[Anemia]]
**Without tx the hematocrit in ESRD patients should stabilize at 15-20%
**Without treatment, the hematocrit in ESRD patients should stabilize at 15-20%
**Treatment = erythropoietin
**Treatment = erythropoietin
*Immunodeficiency
*Immunodeficiency
*Bleeding diathesis ([[Uremic bleeding syndrome]])
*Bleeding diathesis ([[Uremic bleeding syndrome]])
**Increased risk for of bleeding (GI, ICH, liver hematoma) due to impaired plt function
**Increased risk for of bleeding (GI, ICH, liver hematoma) due to impaired platelet function
**Treatment = desmopressin, cryoprecipitate, conjugated estrogen, EPO, dialysis<ref>Hedges SJ et al. Evidence-based treatment recommendations for uremic bleeding. Nature Clinical Practice Nephrology (2007) 3, 138-153.</ref>
**Treatment = desmopressin, cryoprecipitate, conjugated estrogen, EPO, dialysis<ref>Hedges SJ et al. Evidence-based treatment recommendations for uremic bleeding. Nature Clinical Practice Nephrology (2007) 3, 138-153.</ref>


Line 83: Line 83:
*Generated from crystallized nitrogenous waste from sweat
*Generated from crystallized nitrogenous waste from sweat
*Typically in BUN > 200 mg/dL
*Typically in BUN > 200 mg/dL
*Tx is lowering BUN
*Treatment is lowering BUN


===Renal bone disease===
===Renal bone disease===
Line 90: Line 90:
**Symptoms of pseudogout, skin/finger necrosis (small vessel involvement)
**Symptoms of pseudogout, skin/finger necrosis (small vessel involvement)
**Life-threatening calcifications can occur in the cardiac and pulmonary systems
**Life-threatening calcifications can occur in the cardiac and pulmonary systems
**Tx = use of low-calcium dialysate and phosphate-binding gels
**Treatment = use of low-calcium dialysate and phosphate-binding gels
*Hyperparathyroidism (osteitis fibrosa cystica)
*Hyperparathyroidism (osteitis fibrosa cystica)
**Calciphylaxis + vitamin D3 deficiency results in depressed Ca, stimulation of PTH
**Calciphylaxis + vitamin D3 deficiency results in depressed Ca, stimulation of PTH
**Leads to high bone turnover > weakened bones > increased fracture susceptibility
**Leads to high bone turnover -> weakened bones -> increased fracture susceptibility
**Tx = phosphate binding gels, vitamin D3 replacement
**Treatment = phosphate binding gels, vitamin D3 replacement
*Vitamin D3 deficiency and aluminum intoxication (osteomalacia)
*Vitamin D3 deficiency and aluminum intoxication (osteomalacia)
**Leads to osteomalacia (defect in bone calcification)
**Leads to osteomalacia (defect in bone calcification)
**Symptoms similar to hyperparathyroidism (muscle weakness, bone pain)
**Symptoms similar to hyperparathyroidism (muscle weakness, bone pain)
**Tx = desferrioxamine
**Treatment = desferrioxamine
*Amyloidosis
*Amyloidosis
**Common in patients >50yr who have received dialysis for >10yr
**Common in patients >50yo who have received dialysis for >10yr
**Complications: GI perforation, bone cysts w/ pathologic fracture, arthropathies
**Complications: GI perforation, bone cysts with pathologic fracture, arthropathies


===Anion Gap Metabolic Acidosis<ref>Angus S. Uremic Acidosis. University of Connecticut, 2006. http://fitsweb.uchc.edu/student/selectives/TimurGraham/Uremia.html</ref><ref>Nickson C. Renal Tubular Acidosis and Uraemic Acidosis. LITFL. http://lifeinthefastlane.com/ccc/renal-tubular-acidosis/.</ref>===
===Anion Gap Metabolic Acidosis<ref>Angus S. Uremic Acidosis. University of Connecticut, 2006. http://fitsweb.uchc.edu/student/selectives/TimurGraham/Uremia.html</ref><ref>Nickson C. Renal Tubular Acidosis and Uraemic Acidosis. LITFL. http://lifeinthefastlane.com/ccc/renal-tubular-acidosis/.</ref>===
*Early CKD associated with hyperchloremic normal anion gap metabolic acidosis
*Early chronic kidney disease associated with hyperchloremic normal anion gap metabolic acidosis
*Late stage disease causes anion gap
*Late stage disease causes anion gap
**Failure to excrete acid anions, phosphate and sulfate
**Failure to excrete acid anions, phosphate and sulfate
**Bone demineralization - bone buffers H+, releasing calcium from bone, leads to osteopenia
**Bone demineralization - bone buffers H+, releasing calcium from bone, leads to osteopenia
*Tx: PO sodium bicarbonate 1 mEq/kg/day
*Treatment: PO sodium bicarbonate 1 mEq/kg/day


==References==
==References==
<references/>
<references/>
[[Category:Renal]]
[[Category:Renal]]

Revision as of 20:19, 12 July 2016

Background

  • Uremia = clinical syndrome associated with end-stage renal disease
    • Correlation exists between symptoms of uremia and low GFR (15-20% of nl)
    • BUN/Cr are inaccurate markers of clinical syndrome of uremia
  • Contributing Factors:
    • Excretory failure
      • Leads to toxin accumulation
    • Biosynthetic failure
      • Loss of Vitamin D and erythropoietin
    • Regulatory failure
      • Uremic state produces excess free radicals -> atherosclerosis, amyloidosis

Clinical Features and Management

Neurologic

  • Uremic encephalopathy
    • Diagnosis of exclusion
    • Cognitive defects, memory loss, decreased attentiveness, slurred speech
    • Asterixis, seizure, coma
    • Improves with dialysis
  • Dialysis dementia
    • Similar to uremic encephalopathy except progressive, no improvement w/ dialysis
    • EEG findings can differentiate uremic encephalopathy from dialysis dementia
  • CVA
    • Cerebrovascular disease, trauma, bleeding dyscrasias, anticoagulant, HTN
  • Subdural hematoma
    • 10 times more likely than in general population
    • Headache, focal neurologic deficits, seizure, coma
  • Peripheral neuropathy
    • Occurs in 60-100% of dialysis patients
    • Paresthesias, impaired proprioception, weakness
    • Autonomic neuropathy (postural dizziness, gastroparesis, bowel dysfunction)

Cardiovascular

  • CK-MB and troponin are specific markers of MI even in patients undergoing regular dialysis
  • Mortality from CV disease is 10-30 times higher in dialysis patients than general population
  • HTN is common
  • Uremic cardiomyopathy
    • Diagnosis of exclusion
    • Circulating digitalis-like substances have been implicated
    • Dialysis rarely improves LV function
  • Pericarditis
    • Uremic pericarditis (75% of cases)
      • Most common when the other symptoms of uremia are most severe
      • BUN is nearly always >60
      • Loud friction rub that is often palpable
      • Typical pericarditis ECG changes are absent (inflammation does not involve myocardium)
        • If ECG does have typical changes consider infection
    • Dialysis-related (25% of cases)
      • Most common during increased catabolism (trauma, sepsis) or missed dialysis sessions
      • Constitutional symptoms, such as fever, are more common than in uremic pericarditis
    • Treatment
      • Dialysis
  • Tamponade
    • Presents with altered mental status, hypotension, dyspnea
      • Rarely present w/ classic signs of Beck's triad
    • Pericardiocentesis should only be attempted if hemodynamically unstable
  • Pulmonary Edema
    • Commonly ascribed to fluid overload; also consider MI
      • Treat similar to non-ESRD patient
        • Lasix 80mg IV may be effective even if minimal urine output (pulmonary vasodilation)
      • Preload reduction can be accomplished via:
        • Induced diarrhea (sorbitol)
        • Phlebotomy - withdrawal of as little as 150 mL is safe and effective
  • CHF
    • May be preexisting
    • May be caused by uremic cardiomyopathy, fluid overload, AV-related high-output failure

Hematologic

  • Anemia
    • Without treatment, the hematocrit in ESRD patients should stabilize at 15-20%
    • Treatment = erythropoietin
  • Immunodeficiency
  • Bleeding diathesis (Uremic bleeding syndrome)
    • Increased risk for of bleeding (GI, ICH, liver hematoma) due to impaired platelet function
    • Treatment = desmopressin, cryoprecipitate, conjugated estrogen, EPO, dialysis[1]

GI

  • Anorexia, N/V
  • Increased incidence of GI bleeding, diverticular disease, ascites

Dermatologic

  • Uremic frost
  • Generated from crystallized nitrogenous waste from sweat
  • Typically in BUN > 200 mg/dL
  • Treatment is lowering BUN

Renal bone disease

  • Metastatic calcification (calciphylaxis)
    • When calcium-phosphate product (Ca x PO4) > 70-80, metastatic calcification can ensue
    • Symptoms of pseudogout, skin/finger necrosis (small vessel involvement)
    • Life-threatening calcifications can occur in the cardiac and pulmonary systems
    • Treatment = use of low-calcium dialysate and phosphate-binding gels
  • Hyperparathyroidism (osteitis fibrosa cystica)
    • Calciphylaxis + vitamin D3 deficiency results in depressed Ca, stimulation of PTH
    • Leads to high bone turnover -> weakened bones -> increased fracture susceptibility
    • Treatment = phosphate binding gels, vitamin D3 replacement
  • Vitamin D3 deficiency and aluminum intoxication (osteomalacia)
    • Leads to osteomalacia (defect in bone calcification)
    • Symptoms similar to hyperparathyroidism (muscle weakness, bone pain)
    • Treatment = desferrioxamine
  • Amyloidosis
    • Common in patients >50yo who have received dialysis for >10yr
    • Complications: GI perforation, bone cysts with pathologic fracture, arthropathies

Anion Gap Metabolic Acidosis[2][3]

  • Early chronic kidney disease associated with hyperchloremic normal anion gap metabolic acidosis
  • Late stage disease causes anion gap
    • Failure to excrete acid anions, phosphate and sulfate
    • Bone demineralization - bone buffers H+, releasing calcium from bone, leads to osteopenia
  • Treatment: PO sodium bicarbonate 1 mEq/kg/day

References

  1. ↑ Hedges SJ et al. Evidence-based treatment recommendations for uremic bleeding. Nature Clinical Practice Nephrology (2007) 3, 138-153.
  2. ↑ Angus S. Uremic Acidosis. University of Connecticut, 2006. http://fitsweb.uchc.edu/student/selectives/TimurGraham/Uremia.html
  3. ↑ Nickson C. Renal Tubular Acidosis and Uraemic Acidosis. LITFL. http://lifeinthefastlane.com/ccc/renal-tubular-acidosis/.
Retrieved from "https://www.wikem.org/w/index.php?title=Uremia&oldid=84322"